Recommendations for the macroscopic description and oncologic pathology report in precancerous lesions and invasive cervical cancer;Pathologisch-anatomische aufarbeitung und morphologische basisinformationen für das management von dysplasien und karzinomen der cervix uteri

Zentralblatt fur Gynakologie

Volumn 123, Issue 5, 2001, Pages 255-265

  Horn, L C ^a   Fischer, U ^a   Bilek, K ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Cancer; Cervix; Examination; Histology; Konization; Pathology report; Precancerous lesions

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; COLPOSCOPY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LYMPH NODE METASTASIS; PRACTICE GUIDELINE; PRECANCER; UTERINE CERVIX CANCER; UTERINE CERVIX CONIZATION; WART VIRUS;

CERVIX UTERI; DOCUMENTATION; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0034993618     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14792     Document Type: Article

References (77)

1. Rationale for using pathologic tumor dimension and nodal status to subclassify surgically treated stage IB cervical cancer patients
2. Arbeitsgemeinschaft gynäkologische onkologie. Ago-leitlinien zur interdisziplinären diagnostik und therapie des zervixkarzinoms
3. Transformation zone location and intraepithelial neoplasia of the cervix uteri
4. Radical hysterectomy for invasive cancer: A 25-year prospective experience with the Miami technique
5. FIGO classifications and clinical practice guidelines in the management of gynecologic cancers
6. Lymphatic spread of cervical cancer: An anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and para-aortic lymphadenectomy
7. Treatment of carcinoma in situ: Evaluation of 1 609 cases
8. Prognostic factors and operative treatment of stage I B and II B cervical cancer
9. Local spread and lymph node involvement in cervical cancer
10. Residual disease after cone biopsy: Completeness of excision and follow-up cytology as predictive factors
11. Prognostic factors of primary adenocarcinomas of the uterine cervix
12. Histopathologische und immunhistochemische diagnostik. Voraussetzungen zur Optimierung der Aussage
13. Chemoradiation for cervical cancer
14. Lymphovascular space involvment in cervical cancer: An independent risk factor
15. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine and vulvar malignancies
16. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage I B cervical carcinoma
17. Close vaginal margins as a prognostic factor after radical hysterectomy
18. Prognostic factors in patients with cervix cancer treated by radiation therapy: Results of a multiple regression analysis
19. Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer
20. Impact of surgical staging in women with locally advanced cervical cancer
21. Providing human tissue for research
22. Prognosefaktoren des prostatakarzinoms
23. Classification of isolated tumor cells and micrometastases
24. Uterine cervix
25. Stage IB squamous cell cancer of the cervix: Clinicopathologic features related to survival
26. Histopathologische prognosefaktoren beim primär operativ therpierten zervixkarzinom
27. Das neuroendokrin differenzierte karzinom der cervix uteri
28. Histopathologisches korrelat falsch-positiver zytologiebefunde der cervix uteri
29. Leitfaden für die präparation uteriner operationspräparate
30. Standardisierte pathoanatomische befunddokumentation auf den ADT-tumorbögen für malignome des mundes, der kiefer und des gesichts (Version III)
31. Loss of heterozygosity in clinical stage IB cervical carcinoma: Relationship with clinical and histopathological features
32. The prognostic significance of number of positive nodes in cervical carcinoma stages I B, II A and II B
33. Tumors of the uterine isthmus: Clinicopathologic features and immunohistological characterization of p53 expression and hormone receptors
34. How shall we apply the new biology to diagnostic surgical pathology?
35. Laparoscopic sentinel lymph node detection in patients with cervical cancer
36. Value of a complete lymphadenectomy in the radical treatment of cancer on the cervix
37. 18FDG-positronen-emissions-tomographie beim zervixkarzinom: Erste ergebnisse
38. Protocol for the examination of specimens from patients with carcinomas of the cervix. A basis for checklists
39. Das Parametrium
40. Recommendations for the reporting of surgical specimens containing uterine cervical neoplasms
41. Risk factors for recurrence in patients with stage IB, IIA and II B cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation
42. An analysis of cell type in patients with surgically staged IB carcinoma of the cervix: A Gynecologic Oncology Group Study
43. Lymphati c spread in stage I B an II cervical carcinoma: Anatomy and surgical implications
44. Bildgebende diagnostik beim invasiven zervixkarzinom: MRT, CT und ultraschall
45. Die bedeutung der konisation für die früherkennung des zervixkarzinoms. Histologische konustechnik und schnittzahl - Ergebnisse 1966 bis 1985
46. Die ausbreitung des cervixkrebses auf die parametrien und die lymphknoten der beckenwand
47. Natural history of cervical intraepithelial neoplasia - A critical review
48. Atypical immature metaplastic-like proliferations of the cervix: Diagnostic reproducibility and viral (HPV) correlates
49. Clinicians are from Mars and pathologists from Venus. Clinician interpretation of pathology reports
50. The new biology: Histopathology
51. Morphologische veränderungen der zervix nach messerkonisation
52. Diagnostik und therapie zervikaler plattenepitheldysplasien
53. Synoptic reports in gynecologic pathology
54. Gross description, processing and reporting of gynecologic and obstetric specimen
55. Guidelines for handling of most common and important surgical specimens
56. Neue konzepte für staging und therapie des gebärmutterhalskrebses durch endoskopische operationsverfahren
57. Stage I B and II A cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy
58. "Survival tree analysis" - Eine neue methode zur multivariaten bewertung von prognosefaktoren beim operablen zervixkarzinom
59. Histologische regression des mammakarzinoms nach primärer (neoadjuvanter) chemotherapie
60. Radical hysterectomy for stage IB adenocarcinoma of the cervix: The University of Miami experience
61. Ovarian metastases in stage I B carcinoma of the cervix: A Gynecologic Oncology Group Study
62. Improved treatment for cervical cancer - Concurrent chemotherapy and radiotherapy
63. Prognosefaktoren des radikal operierten zervixkarzinoms im stadium I B
64. Sentinel node detection in cervical cancer
65. Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy?
66. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow
67. Modified radical hysterectomy for early I B cervical cancer
68. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas
69. Histopathological predictors of the behavior of surgically treated stage I b squamous cell carcinoma of the cervix
70. The oncologic pathology report. Quality by design